VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO WCGIC 2020 | ILOC: synergism of immunomodulation and tumour ablation in CRC

Thibaud Kössler, MD, PhD, of Geneva University Hospital, Geneva, Switzerland, describes the ILOC study (NCT03101475), evaluating the synergism of immunomodulation and tumor ablation in patients with incurable liver metastases from colorectal cancer (CRC). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter